You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ticagrelor

Showing 1 - 25 of 608
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Coronary Syndrome, STEMI, NSTEMI Trial in Naples (Ticagrelor 90mg, Ticagrelor 60 mg)

Completed
  • Acute Coronary Syndrome
  • +4 more
  • Ticagrelor 90mg
  • Ticagrelor 60 mg
  • Naples, Italy
    Professor Giovanni Esposito
Jul 6, 2022

Healthy Individuals Trial in Karachi (Anplag (Ticagrelor 90 mg), Brilinta (Ticagrelor 90 mg))

Completed
  • Healthy Individuals
  • Anplag (Ticagrelor 90 mg)
  • Brilinta (Ticagrelor 90 mg)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research
Aug 11, 2022

Saphenous Vein Graft Disease Trial in Boca Raton, Ottawa (Aspirin, Ticagrelor)

Completed
  • Saphenous Vein Graft Disease
  • Boca Raton, Florida
  • +1 more
May 16, 2022

Acute Myocardial Infarction Trial in Gothenburg (Ticagrelor 90mg)

Recruiting
  • Acute Myocardial Infarction
  • Ticagrelor 90mg
  • Gothenburg, Sweden
    Kardiologen
Jun 7, 2022

Acute Myocardial Infarction, Ticagrelor Trial in Busan (Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg)

Recruiting
  • Acute Myocardial Infarction
  • Ticagrelor
  • Clopidogrel 75 mg
  • +2 more
  • Busan, Korea, Republic of
    DongA University Hospital
Jan 14, 2022

Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet)

Recruiting
  • Ischemic Stroke
  • Ticagrelor 90 MG Oral Tablet
  • Clopidogrel tablet
  • Kafr Ash Shaykh, Egypt
    Kafr Elsheikh University Hospital
Nov 18, 2022

Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,

Not yet recruiting
  • Acute Coronary Syndrome
  • Percutaneous Coronary Intervention
  • Standard-DAPT of Ticagrelor plus aspirin
  • Sequential monotherapy of Ticagrelor and clopidogrel
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
May 31, 2022

Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon Trial in Xi'an (Aspirin 100mg for 1-month (immediately after

Recruiting
  • Antiplatelet Drug
  • +2 more
  • Aspirin 100mg for 1-month (immediately after PCI)
  • +4 more
  • Xi'an, Shannxi, China
    Ling Tao
Jul 20, 2022

Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina Trial

Not yet recruiting
  • Non ST Segment Elevation Acute Coronary Syndrome
  • +2 more
  • De-escalation to ticagrelor 60 mg at day 30
  • +3 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
    Department of Cardiology, Dr. A. Jurasz University Hospital, Col
Mar 9, 2023

Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor monotherapy, Ticagrelor plus aspirin, Clopidogrel

Recruiting
  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease
  • Ticagrelor monotherapy
  • +2 more
  • Jacksonville, Florida
    University of Florida
May 31, 2022

Coronary Artery Disease Trial in Jacksonville (Cangrelor, Placebo)

Completed
  • Coronary Artery Disease
  • Jacksonville, Florida
    University of Florida Jacksonville
Feb 3, 2022

Coronary Artery Disease Trial in Aalst (Ticagrelor, Prasugrel)

Completed
  • Coronary Artery Disease
  • Aalst, Belgium
    Aalst cardiovascular center
Nov 30, 2022

Percutaneous Coronary Intervention Trial in Sayre (Fentanyl, Ticagrelor 90Mg Tablet)

Recruiting
  • Percutaneous Coronary Intervention
  • Sayre, Pennsylvania
    The Guthrie Clinic
Dec 14, 2021

Coronary Artery Disease Trial in São Paulo (Prasugrel, Ticagrelor)

Completed
  • Coronary Artery Disease
  • São Paulo, Sao Paulo, Brazil
    Heart Institute (InCor) / University of São Paulo
Feb 9, 2022

Senior Acute Coronary Syndrome Patients After PCI Trial in Shanghai (Ticagrelor)

Recruiting
  • Senior Acute Coronary Syndrome Patients After PCI
  • Ticagrelor
  • Shanghai, Shanghai, China
    shanghai Tongren hospital
Mar 12, 2022

Atrial Fibrillation, Acute Coronary Syndrome Trial in Ottawa (Ticagrelor, Rivaroxaban)

Active, not recruiting
  • Atrial Fibrillation
  • Acute Coronary Syndrome
  • Ottawa, Ontario, Canada
    University of Ottawa Heart Institute
Jun 6, 2022

Platelet Reactivity Trial in Harbin (Ticagrelor 90mg, Clopidogrel 75mg)

Completed
  • Platelet Reactivity
  • Ticagrelor 90mg
  • Clopidogrel 75mg
  • Harbin, Heilongjiang, China
    Thrombelastogram
Dec 20, 2021

Peripheral Artery Disease, Type 2 Diabetes Trial in New York (Aspirin, Ticagrelor, Aspirin Placebo)

Completed
Has Results
  • Peripheral Artery Disease
  • Type 2 Diabetes
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 18, 2022

Acute Coronary Syndrome Trial in Lund (Prasugrel 10 mg p.o, Ticagrelor 90 mg)

Recruiting
  • Acute Coronary Syndrome
  • Prasugrel 10 mg p.o
  • Ticagrelor 90 mg
  • Lund, Sweden
    Dep. Cardiology, Skånes universitetssjukhus
Mar 16, 2022

Acute Coronary Syndrome Patients With Diabetes After PCI Trial in Shanghai (Ticagrelor, Aspirin)

Recruiting
  • Acute Coronary Syndrome Patients With Diabetes After PCI
  • Shanghai, China
    shanghai Tongren hospital
Mar 12, 2022

Stroke, Stroke, Ischemic, Atherosclerosis Trial in Paris (Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg)

Not yet recruiting
  • Stroke
  • +7 more
  • Colchicine 0.5 MG
  • +2 more
  • Paris, France
    URC Lariboisière-Fernand Widal-Saint Louis
Aug 2, 2022

Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular

Not yet recruiting
  • Cerebral Infarction
  • +3 more
    • (no location specified)
    Jan 29, 2023

    Platelet Reactivity Trial in Harbin (low-dose ticagrelor, Clopidogrel)

    Completed
    • Platelet Reactivity
    • Harbin, California, China
      VerifyNow
    Dec 20, 2021

    Acute Coronary Syndrome, Coronary Stent Implantation Trial in China (Ticagrelor 60mg, Ticagrelor 90mg)

    Recruiting
    • Acute Coronary Syndrome
    • Coronary Stent Implantation
    • Ticagrelor 60mg
    • Ticagrelor 90mg
    • Taishan, Guangdong, China
    • +6 more
    Mar 21, 2022

    Rheumatoid Arthritis Trial in New York (Ticagrelor, MTX therapy)

    Completed
    Has Results
    • Rheumatoid Arthritis
    • Ticagrelor
    • MTX therapy
    • New York, New York
      New York University School of Medicine
    Sep 27, 2021